Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
VIDEO: Administering medication through the lymphatic system for rheumatoid arthritis
SAN DIEGO — In this Healio video, Jeffrey A. Sparks, MD, MMSc, discusses results from a proof-of-concept study that assessed the efficacy of administering medication for rheumatoid arthritis into the peripheral lymphatic systems.
VIDEO: ‘Eye-opening’ results suggest low-dose prednisone associated with adverse events
SAN DIEGO — Jeffrey A. Sparks, MD, MMSc, spoke with Healio about two “high-impact” presentations from ACR Convergence 2023 that assessed dosing of prednisone for patients with rheumatoid arthritis.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: ‘Practice affirming’ findings from split-dosing methotrexate study at ACR
SAN DIEGO — In this video, Healio spoke with Jeffrey A. Sparks, MD, MMSc, results from a study conducted in India assessing the efficacy of treating rheumatoid arthritis with split-doses of methotrexate.
Odds of opioid use in autoimmune rheumatic disease decreased 15% annually after 2014
SAN DIEGO — The likelihood of opioid use among patients with autoimmune rheumatic disease has decreased annually by 15% since 2014, according to data presented at ACR Convergence 2023.
FDA testing finds hidden ingredients in products marketed for arthritis, pain
The FDA has advised consumers to exercise caution before using certain products promoted for arthritis and pain, as some have been found to contain hidden ingredients that may pose a significant health risk.
Small-dose, short-duration glucocorticoid use increases risk for cardiac events in RA
SAN DIEGO — Glucocorticoid doses as small as 5 mg per day, in durations as short as 30 days, and a use period as long as 1 year all increase the risk for major adverse cardiac events in rheumatoid arthritis, said a speaker here.
Highlights from ACR Convergence 2023
In this episode of Meeting Mic, we bring you Healio’s top headlines from ACR Convergence 2023.
AI model predicts joint damage in RA; only meant to complement, ‘not replace the human’
SAN DIEGO — An automated deep learning model accurately identified and predicted joint space narrowing and erosion based on hand radiographs of patients with rheumatoid arthritis, according to data presented at ACR Convergence 2023.
Telitacicept yields ‘really exciting’ results in rheumatoid arthritis structural damage
SAN DIEGO — Patients treated with telitacicept demonstrated improvements in American College of Rheumatology response and structural damage in patients with rheumatoid arthritis, according to data presented at ACR Convergence 2023.
‘On the cusp’ of something big: New insights into the microbiome’s role in immunity
As of just a few years ago, early enthusiasm over the apparent interplay between the gut microbiome and the immune system, and that it was driving or exacerbating certain rheumatic diseases, seemed to have all but dried up.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read